AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $205,091,507 | +4.8% | 2,934,490 | +7.7% | 0.01% | +20.0% |
| Q2 2023 | $195,713,800 | +28.6% | 2,723,543 | +10.3% | 0.01% | +25.0% |
| Q1 2023 | $152,240,056 | -21.1% | 2,468,224 | -1.4% | 0.00% | -33.3% |
| Q4 2022 | $193,054,615 | +97.4% | 2,502,977 | +14.2% | 0.01% | +100.0% |
| Q3 2022 | $97,819,000 | +14.6% | 2,192,255 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $85,375,000 | -1.4% | 2,229,077 | +6.5% | 0.00% | +50.0% |
| Q1 2022 | $86,600,000 | +8.7% | 2,092,257 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $79,700,000 | +16.9% | 2,109,622 | +2.0% | 0.00% | 0.0% |
| Q3 2021 | $68,165,000 | -52.4% | 2,068,063 | -2.5% | 0.00% | -50.0% |
| Q2 2021 | $143,067,000 | +8.9% | 2,120,754 | -8.6% | 0.00% | 0.0% |
| Q1 2021 | $131,346,000 | -29.3% | 2,319,793 | +1.8% | 0.00% | -33.3% |
| Q4 2020 | $185,733,000 | +15.2% | 2,279,766 | +0.7% | 0.01% | 0.0% |
| Q3 2020 | $161,291,000 | -18.1% | 2,263,759 | -5.4% | 0.01% | -25.0% |
| Q2 2020 | $196,934,000 | +48.5% | 2,393,467 | +6.2% | 0.01% | +33.3% |
| Q1 2020 | $132,641,000 | -40.6% | 2,254,650 | +4.4% | 0.01% | -33.3% |
| Q4 2019 | $223,283,000 | +509.2% | 2,160,246 | +19.3% | 0.01% | +350.0% |
| Q3 2019 | $36,652,000 | -15.8% | 1,810,877 | +7.1% | 0.00% | 0.0% |
| Q2 2019 | $43,531,000 | +557.1% | 1,690,522 | +263.1% | 0.00% | – |
| Q1 2019 | $6,625,000 | +3560.2% | 465,587 | +626.9% | 0.00% | – |
| Q4 2018 | $181,000 | -6.2% | 64,049 | +14.6% | 0.00% | – |
| Q3 2018 | $193,000 | +12.2% | 55,912 | +4.1% | 0.00% | – |
| Q2 2018 | $172,000 | +49.6% | 53,717 | +15.1% | 0.00% | – |
| Q1 2018 | $115,000 | -56.6% | 46,659 | -1.4% | 0.00% | – |
| Q4 2017 | $265,000 | +5.6% | 47,303 | +4.5% | 0.00% | – |
| Q3 2017 | $251,000 | -2.3% | 45,263 | -2.9% | 0.00% | – |
| Q2 2017 | $257,000 | -86.6% | 46,621 | -90.5% | 0.00% | – |
| Q1 2017 | $1,917,000 | +63800.0% | 491,505 | +117204.3% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 419 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 419 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | – | 419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |